Medical Nutrition

The effects of bacteria on the gut will be discussed at the conference

Probiotic industry value set to reach £29bn

By Nicholas Robinson

Sales of probiotic food, drink and supplements are set to reach £29bn by 2018, as consumers seek food-based answers to health issues, according to one expert commentator.

SNE: “We urge European decision makers to now translate this updated scientific evidence into legislation...

“This signals a new dawn for weight loss products.”

Industry backs EFSA report on low-calorie diet regimes

By Shane STARLING

EFSA’s full low-calorie diet regime report – published this week – can help “tackle the societal challenge of obesity”, the EU’s specialist food trade group has said.

On-pack probiotic claims possible with medical women's health products, says Danish supplier Bifodan

Is the future of women’s health probiotics medical?

By Annie Harrison-Dunn

Danish probiotic firm Bifodan has created a second business unit for probiotics targeting women’s intimate health, splitting the business between dietary supplements and over-the-counter (OTC) medical products.  

Germvangelist set to shake Probiota with holistic shout

Coming to Probiota 2015 - February 3-5, Amsterdam

Germvangelist set to shake Probiota with holistic shout

By Shane STARLING

Self-styled 'germvangelist' and microbiologist Jason Tetro says the probiotic industry is obsessed with technicalities and needs to venture back in time to access the innate, holistic power of probiotics.

How hemp seed oil could offer new hope to epilepsy sufferers

Soapbox

How hemp seed oil could offer new hope to epilepsy sufferers

By Paul Benhaim

It is well established that the brain has metabolic requirements that must be satisfied by what we eat or in the case of infants, “what their mother eats”. In particular, dietary fats are fundamentally important for thinking, learning and memory abilities,...

SATIN chief: “...even if not combined with another effective mono-therapy it could become a very powerful tool.”

"We hope to develop a pill for fexaramine within 24 to 36 months to try in humans."

Satiety pill shows metabolic syndrome potential: Mice study

By Shane STARLING

The mainstream press has latched onto a mouse study that shows a bile-controlling, gut restricted pharma intervention can mimic food intake and therefore potentially be an obesity beater. But could it pass clinical inspection? One weight loss researcher...

Follow us

Featured Events

View more

Products

View more

Webinars